| Last update: 12.09.2025 15:25:00 |
Early-Bird-Symposium Dr. Falk Pharma AG: Long-term treatment of EOE: Latest evidence | ||||
| 07:45 - 08:15 | Early-Bird-Symposium Dr. Falk Pharma AG: Long-term treatment of EOE: Latest evidence Chair: Christoph Schlag, Zürich / Alain Schoepfer, Lausanne | 11.09.25 16:12 | ||
EoE Update [sponsored by Sanofi-Aventis] | ||||
| 08:30 - 10:00 | EoE Update [sponsored by Sanofi-Aventis] Chair: Alain Schoepfer, Lausanne / Alex Straumann, Zürich | 11.09.25 16:13 | ||
| 08:30 - 09:00 | Updated European EoE guidelines 2025: what has changed? Thomas Greuter, Lugano | 12.09.25 08:19 | ||
| 09:00 - 09:30 | Targeted therapies in EoE Luc Biedermann, Zürich | 11.09.25 15:37 | ||
| 09:30 - 10:00 | Diets in EoE: do they work? Alfredo J Lucendo, Tomelloso | 12.09.25 07:35 | ||
Lunch symposium Takeda: A decade of Vedolizumab: Learning from the past, treating the present, personalizing the future. | ||||
| 12:15 - 12:45 | Lunch symposium Takeda: A decade of Vedolizumab: Learning from the past, treating the present, personalizing the future. Chair: Luc Biedermann, Zürich / Sebastian Zeissig, Greifswald | |||
Lunch symposium Johnson&Johnson: Breaking Barriers: Advancing IBD Treatment through Innovative: Therapies and Safety Insights | ||||
| 12:50 - 13:20 | Lunch symposium Johnson&Johnson: Breaking Barriers: Advancing IBD Treatment through Innovative: Therapies and Safety Insights Chair: Stephan Brand, St. Gallen / Pascal Juillerat, Bern and Fribourg / Frank Seibold, Bern | 12.09.25 10:28 | ||
Gastroenterology oral presentations | ||||
| 13:30 - 15:00 | Gastroenterology oral presentations Chair: Jean-Louis Frossard, Genève / Jan Hendrik Niess, Basel | |||
| 13:30 - 13:55 | GI effects of GLP1 agonists Emanuel Christ, Basel | 12.09.25 09:44 | ||
| 14:00 - 14:10 | Eosinophil subset dynamics and transcriptional signatures in colorectal cancer progression Glenn De Lange, Zurich | 12.09.25 10:07 | ||
| 14:10 - 14:20 | Rising Incidence of Helicobacter pylori Antibiotic Resistance in Eastern Switzerland: HARRiS Trial - An Interim Analysis Alexander Kueres-Wiese, St. Gallen | 12.09.25 08:43 | ||
| 14:20 - 14:30 | Cyp2s1-dependent modulation of the intestinal metabolome and microbiome Sara Dylgjeri, Basel | 12.09.25 12:34 | ||
| 14:30 - 14:40 | A2 beta casein milk and its impact on histological disease activity and on in-vitro models of eosinophilic esophagitis Emilie Gueguen, Zurich | 12.09.25 12:35 | ||
| 14:40 - 14:50 | A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammation Manuel Jakob, Bern | 12.09.25 12:12 | ||
| 14:50 - 15:00 | Establishing Reference Intervals for Area Under the Curve and Slope in Gastric Emptying Scintigraphy using the Mixed Nottingham Test Meal Matteo Piazza, Bern | 12.09.25 10:47 | ||
Young Gastroenterologists: Parachute Interlaken. My parachute for the exam and clinical practice | ||||
| 15:30 - 17:00 | Young Gastroenterologists: Parachute Interlaken. My parachute for the exam and clinical practice Chair: Sena Blümel, Zürich / Daniele Riva, Lugano | |||
| 15:30 - 15:52 | How to prep and slay the exam Manuel Lehner, Basel | 11.09.25 14:37 | ||
| 15:52 - 16:14 | Nutrition - the dirty basics for the European Board Marius König, St. Gallen | 12.09.25 10:58 | ||
| 16:14 - 16:36 | Non Variceal Bleeding - what's in the Guidelines Costanza De Maria, Bellinzona | 12.09.25 08:52 | ||
| 16:36 - 17:00 | Fatty Liver and all its friends - what to know Sena Blümel, Zürich | 12.09.25 12:14 | ||